Business description
Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and therapeutics through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products systems and services that meet the ever-changing and rapidly growing needs of health care both today and into the future. Underpinning Enzo Biochem’s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.
Management board & Supervisory board
| CEO |
| Dr. Elazar Rabbani |
| Management board |
| David Bench, Barry W. Weiner, Dieter Schapfel, MD, Kara Cannon |
| Supervisory board |
| Dr. Elazar Rabbani, Dov Perlysky, Ian B. Walters, Mary Tagliaferri, Rebecca Fischer |
Company data
| Name: |
Enzo Biochem Inc. |
| Address: |
527 Madison Avenue,New York, New York 10022, USA |
| Phone: |
+1-212-583-0100 |
| Fax: |
+1-212-679-7999 |
| E-mail: |
info@enzo.com
|
| Internet: |
www.enzo.com |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
07-31 |
| Free Float: |
67.10% |
| IPO date: |
- |
